Key Points
- Agency Appointment: The Brill Building has been appointed by Irish femtech firm Coroflo to handle its brand strategy, campaign development, production, PR, and communications for its UK expansion.
- Product Focus: The campaign centers on launching Coro, a groundbreaking breastfeeding technology developed by Coroflo to monitor milk flow and volume accurately.
- Target Audience & Campaign Strategy: The UK campaign specifically targets media outlets and influencers, relying on genuine experiences and stories from real mothers.
- Company Leadership: Coroflo was co-founded by Chief Executive Officer Rosanne Longmore, alongside Dr Helen Barry and engineer Jamie Traverse.
- Core Brief: The agency is tasked with establishing Coro as a category leader across UK parenting, women’s health, and broader femtech discussions.
London (The Leeds Times) August 17, 2026 –In a major move within the health and technology sector, Irish femtech company Coroflo has appointed creative agency The Brill Building to lead the official UK launch of its flagship breastfeeding technology, Coro. The strategic partnership sees The Brill Building taking full responsibility for brand strategy, creative campaign development, video and visual production, public relations, and broader communications across the region. As Coroflo expands beyond its domestic market, the UK rollout represents a key growth phase for the Dublin-founded medical technology enterprise.
The core brief handed to The Brill Building focuses on introducing Coro to UK consumers while positioning the product prominently within the parenting, women’s health, and rapidly growing femtech conversations.
To achieve this, the agency is mounting a consumer-facing communications campaign specifically designed to target national media outlets, specialized parenting publications, and key digital influencers.
Rather than relying on traditional marketing techniques, the initiative is structured entirely around the lived experiences of real mothers and their authentic infant feeding journeys.
What Is the Coro Technology Developed by Coroflo?
Coro is designed as a pioneering solution to one of the most common challenges faced by new parents: determining precise milk intake during breastfeeding.
Developed by Coroflo, the device integrates advanced sensor technology to monitor and measure milk flow in real time without interrupting the natural feeding process.
By providing accurate data directly via a smartphone application, the technology aims to offer reassurance to parents, reduce anxiety regarding infant nutrition, and provide useful data for healthcare professionals monitoring infant development.
The founding team of Coroflo brings together expertise from healthcare, business, and engineering disciplines. Chief Executive Officer Rosanne Longmore led the business formation alongside co-founders Dr Helen Barry and engineer Jamie Traverse.
The team was established with the specific objective of applying precision engineering and clinical understanding to maternal health, identifying a long-standing gap in objective measurement tools for breastfeeding support.
How Will The Brill Building Execute the Campaign?
To establish Coro’s brand presence across the United Kingdom, The Brill Building has designed a multi-faceted communications strategy.
The campaign relies heavily on authentic storytelling, bringing real mothers to the forefront to discuss the physical and emotional realities of infant feeding.
By framing the product through real-world feeding experiences, the agency seeks to foster trust among new and expectant parents while building organic traction across social platforms and editorial outlets.
The scope of work assigned to The Brill Building covers all media touchpoints:
- Strategic Brand Positioning: Defining Coro’s identity within the UK femtech, healthcare, and infant care landscapes.
- Campaign Production: Creating original visual, video, and digital content featuring participating mothers and their infants.
- PR and Earned Media: Securing coverage across national news, consumer lifestyle, parenting, and specialized technology titles.
- Influencer Engagement: Partnering with trusted voices in the parenting and maternal wellness spheres to share peer-to-peer insights.
By combining earned media outreach with peer-led creative assets, the agency aims to ensure Coro becomes a central reference point in discussions surrounding modern parenting tools and technological support for maternal health.
Explore More UK News
UK Government Issues Emergency Wildfire Alert and BBQ Ban: Knowsley 2026
Heathrow Terminal Flooding Restricts Road Access In London 2026
What Is the Background to Coroflo’s UK Expansion?
Coroflo was founded in Ireland to address a persistent clinical and parental challenge: the inability to measure exact milk transfer during breastfeeding. In traditional settings, assessing infant milk intake often relied on weight comparisons before and after feedings or subjective monitoring, both of which can cause distress or uncertainty for new mothers.
Recognizing this issue, Dr Helen Barry and engineer Jamie Traverse conceptualised a low-profile, non-invasive sensor structure capable of measuring fluid movement accurately. Joining forces with business leader Rosanne Longmore, the team established Coroflo to commercialise the innovation.
Prior to entering the UK market, Coroflo underwent years of research, development, clinical validation, and regulatory approval processes to ensure the technology met stringent safety and accuracy standards required for infant health products.
The company secured significant funding from institutional investors, venture capital funds, and state development agencies in Ireland, enabling it to transition from product development to international commercial distribution.
Choosing the UK as its initial international target aligns with the firm’s strategic goal of tapping into a nearby market with high demand for maternal health innovations and an established ecosystem of digital health adoption.
What Is the Industry Prediction for This Expansion and Its Impact on Parents and the Femtech Sector?
The introduction of Coro to the UK market is expected to have a noticeable impact on both new parents and the broader femtech landscape across the region. For parents, particularly mothers navigating the early weeks of infant care, access to objective feeding data is predicted to alleviate significant stress associated with infant weight gain and nutrition.
By replacing guesswork with precise metrics, the technology may empower mothers to continue breastfeeding for longer periods if they choose to do so, while also providing clear diagnostic information for midwives, health visitors, and paediatricians.
From a market perspective, Coroflo’s UK entry signifies the continuing maturation of the global femtech sector, which has increasingly expanded beyond reproductive tracking into maternal health, postpartum care, and medical-grade home monitoring tools.
Industry analysts project that successful execution of the UK campaign by The Brill Building will serve as a blueprint for Coroflo’s eventual expansion into larger international markets, including continental Europe and North America.
Furthermore, as mainstream consumer interest in health metrics grows, the integration of real-time data into infant feeding is likely to encourage further technological development and investment across the maternal and paediatric care sectors.
